Skip to content

Total debt at other companies

Staar Surgical logo
Staar SurgicalSTAA
$37.29M+1.7%
Bausch + Lomb logo
Bausch + LombBLCO
$5.04B+4.3%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
$63.59M+1,750%
IAR
Integra LifeSciencesIART
$1.98B+3.2%
Johnson & Johnson logo
Johnson & JohnsonJNJ
Schering-Plough logo
Schering-PloughSGP

Other financials

Income statement

See full
Revenue$13.4M-5.2%
Gross profit$6.4M-10.4%
Operating income$2.2M+139%
Net income$36.3M+233%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$12.5M-36.1%
Total equity$10.8M+149%
Total assets$66.2M-9.2%

Cash flow

See full
Operating cash flow-$4.3M+38.4%
CapEx$77.0K-31.9%
Free cash flow-

Valuation

See full
Market cap$70.13M-53.1%
Enterprise value$65.21M-54.9%
P/E2.4×
P/S1.2×-1.3×

Profitability

See full
Gross margin45.7%-2.1pp
Operating margin-28.7%+7.3pp
Net margin50.9%+30.7pp
FCF margin-26.6%

Returns & leverage

See full
Return on equity-164%-235pp
Debt / equity0.7×
Current ratio2.4×+0.6×

Where this comes from

Calculated from LENSAR, Inc.’s reported figures.

Plus components not separately reported this period.

The official record: LENSAR, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about LENSAR, Inc.'s total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LENSAR, Inc.'s total debt?
LENSAR, Inc. (LNSR) reported total debt of $7.57M in Q1 2026.
How has LENSAR, Inc.'s total debt changed year-over-year?
LENSAR, Inc.'s total debt increased by 206.3% year-over-year, from $2.47M to $7.57M.
What is the long-term trend for LENSAR, Inc.'s total debt?
Over 5 years (2020 to 2025), LENSAR, Inc.'s total debt has grown at a -6.4% compound annual growth rate (CAGR), from $3.81M to $2.74M.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.